Voyager Life PLC - Director/PDMR Shareholding
Announcement provided by
Mendell Helium plc · MDH17/12/2021 07:00
17 December 2021
Voyager Life plc
("Voyager" or the "Company")
Directors' Dealings
Voyager, the health and wellness company supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, announces that it was informed on 16 December 2021, Nick Tulloch, Chief Executive Officer, and Eric Boyle, Non-Executive Chairman, acquired respectively 537,776 and 519,112 ordinary shares in the Company at a price of
Following these purchases, Nick Tulloch is beneficially interested in 1,321,776 Ordinary Shares, representing 14.3 per cent. of the Company's issued share capital and Eric Boyle is beneficially interested in 840,000 Ordinary Shares, representing 9.1 per cent. of the Company's issued share capital.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into
ENDS
Enquiries:
Voyager
Nick Tulloch - nick@voyagerlife.uk / 01738 505 130
Cairn Financial Advisers LLP (AQSE Corporate Adviser)
Ludovico Lazzaretti or Liam Murray +44 (0) 20 72130 880
Notes to Editors:
About Voyager
Voyager was founded in 2020 and is based in
In line with
Website and social media links:
https://www.instagram.com/voyagercbd/
https://twitter.com/voyagercbd
https://www.linkedin.com/company/voyager-cbd/
https://www.facebook.com/VoyagerCBD/
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
||
|
a) |
Name |
Nicholas Tulloch |
|
|
2. |
Reason for the notification |
||
|
a) |
Position / status |
CEO |
|
|
b) |
Initial notification / amendment |
Initial notification |
|
|
3. |
Details of the issuer, |
||
|
a) |
Name |
Voyager Life plc |
|
|
b) |
LEI |
213800XIUQ3AHRZ6UF89 |
|
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument |
Ordinary shares of |
|
|
b) |
Nature of the transaction |
Acquisition |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
537,776 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information Aggregated volume Price |
537,776 ordinary shares at a price of |
|
|
e) |
Date of the transaction |
16 December 2021 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
||
|
a) |
Name |
Eric Boyle |
|
|
2. |
Reason for the notification |
||
|
a) |
Position / status |
Chairman |
|
|
b) |
Initial notification / amendment |
Initial notification |
|
|
3. |
Details of the issuer, |
||
|
a) |
Name |
Voyager Life plc |
|
|
b) |
LEI |
213800XIUQ3AHRZ6UF89 |
|
|
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument |
Ordinary shares of |
|
|
b) |
Nature of the transaction |
Acquisition |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
519,112 |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
d) |
Aggregated information Aggregated volume Price |
519,112 ordinary shares at a price of |
|
|
e) |
Date of the transaction |
16 December 2021 |
|
|
f) |
Place of the transaction |
Outside a trading venue |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.